.jpg)
.jpg)
Cleveland Clinic
Dr. Campbell obtained BS, MD and PhD degrees at The University of Chicago and then did a Urology Residency at The Cleveland Clinic (1989-1995), followed by a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center (1995-1996). Dr. Campbell’s primary interests have included renal cell carcinoma, bladder cancer, tumor angiogenesis, and urology residency training. His background also includes American Foundation for Urological Diseases (AFUD) and Kimmel Research Scholarship Awards. He has served as Chair of the Exam Committee for the Society of Urologic Oncology and President for the Society of Pelvic Surgeons. Dr. Campbell was recently Chair for the AUA Guidelines Panel for Management of Localized Kidney Cancer (2017), and was Co-Chair for the previous iteration of this in 2009. Dr. Campbell was Co-Editor of Renal Cell Carcinoma (BC Decker, 2009) and Editor of Renal Cell Carcinoma: Clinical Management (Humana Press, 2013) and 100 Questions and Answers about Kidney Cancer (Jones and Bartlett, 2008, 2012, 2015, and 2018). Dr. Campbell has also authored or co-authored “Malignant Renal Tumors” for Campbell/Walsh Urology for the past 5 editions (2000, 2005, 2010, 2015, and 2018)
Over the past 5 years, Dr. Campbell’s academic work has focused on the role of PN and RN in the management of RCC, the determinants of functional recovery after PN, the survival implications of differences in renal function after renal cancer surgery, the use of neoadjuvant TKI’s to enable PN and optimize functional outcomes, and the functional implications of tumor enucleation. Dr. Campbell is also developing and testing a case-based learning program for Kidney/Adrenal Tumors and a simulation and skill curriculum for residency training. .
Disclosure information not submitted.
Friday, May 13, 2022
2:45 PM – 3:00 PM
Saturday, May 14, 2022
3:30 PM – 5:30 PM
Sunday, May 15, 2022
7:30 AM – 9:30 AM